Geneva, June 30 -- International Clinical Trials Registry received information related to the study (ISRCTN64460189) titled 'Study to evaluate the safety, performance and ease of use of a continuous glucose monitoring (CGM) solution in everyday life for people with diabetes' on June 20.
Study Type: Observational
Study Design:
Open-label single-arm prospective non-randomized multi-center study (Diagnostic, Safety, Efficacy)
Primary Sponsor: Roche Diabetes Care GmbH
Condition:
Diabetes mellitus
Nutritional, Metabolic, Endocrine
Intervention:
Subjects will insert a CGM device in the upper arm for continuous measurement of glucose levels in the subcutaneous interstitial fluid. The CGM sensor will be paired with a mobile application f...